Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

KPTI $9.44 2.3162 +32.53%
CCXI $5.25 0.3300 +6.71%
MTP $4.42 0.2400 +5.74%
TGTX $6.45 0.2700 +4.37%
ARWR $7.15 0.2600 +3.77%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARGS $4.67 -0.5550 -10.63%
NYMX $3.57 -0.3850 -9.75%
MNKD $0.68 -0.0631 -8.47%
VRML $1.37 -0.0500 -3.52%
SNSS $0.85 -0.0275 -3.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

How the FDA May Be Repeating Its Morcellator Mistakes On Another Device

(Philadelphia Inquirer/Check Up blog) Aug 10, 2016 - Back in March 2016, one of the most prestigious academic medical journals in the nation published an article entitled “N-of-1 Policymaking — Tragedy, Trade-offs, and the Demise of Morcellation”.
read article 



In China, IBM Watson Partners With Hospitals To Fight Cancer

(Forbes) Aug 11, 2016 - IBM said it has established a beachhead in China for its Watson artificial intelligence system, which will be used to diagnose and treat cancer in a country of 1.4 billion people where access to oncology research is a problem.
read article 



NantHealth's Cancer Test Picks Up More Willing Insurers

(Modern Healthcare) Aug 10, 2016 - NantHealth, the precision-medicine company started by billionaire Dr. Patrick Soon-Shiong, is in negotiations with 13 additional health insurance companies and large employers to cover its costly genome sequencing test for cancer patients.
read article 



MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup Dragonfly Therapeutics

(Xconomy Boston) Aug 11, 2016 - Tyler Jacks is a cancer research pioneer, one of the co-chairs of the White House’s ambitious Cancer “Moonshot” initiative, and has helped advise a number of companies developing cancer drugs over the years. But only now is Jacks building a cancer drug maker of his own: a stealthy startup called Dragonfly Therapeutics.
read article 



Novartis Upends Early-Stage Drug Research

(Forbes) Aug 11, 2016 - A few years ago, researchers at Novartis saw a disconnect between its robust cancer drug development pipeline, and the speed and efficacy by which it tested small molecules on real tumors. So it innovated the way it conducts early-stage research.
read article 



Advaxis Announces that Phase 2 Head and Neck Cancer Study with AXAL Advances to Second Stage

(Yahoo! Finance) Aug 11, 2016 - Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate, axalimogene filolisbac (AXAL), in patients with late-stage HPV-associated oropharyngeal cancer (HPVOPC) met its stage 1 primary objective and is advancing into the second stage of the clinical study.
read article 



PharmaMar Announces the IDMC´S Response on the CORAIL Trial Using PM1183

(PharmaMar) Aug 11, 2016 - PharmaMar announces that it has received the approval from the Independent Data Monitoring Committee (IDMC) to continue with the pivotal CORAIL study of PM1183 (lurbinectedin) in patients with platinum-resistant ovarian cancer up to the recruitment of the 420 patients established in the protocol.
read corporate press release 



Cancer Drug Given to Pregnant Women Could Reduce Fertility of Daughters, Study Suggests

(The Telegraph [UK]) Aug 11, 2016 - A chemotherapy drug given to pregnant cancer patients could reduce the fertility of their daughters, a new study suggests.
read article 



Researchers Devise Method for Bone Marrow Transplants Without Using Chemotherapy

(Stanford Medicine) Aug 10, 2016 - Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects.
read press release 



Pancreatic Cancer Cells Find Unique Fuel Sources to Keep From Starving

(NYU Langone) Aug 10, 2016 - Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition.
read press release 



Brigham Docs Test New Way to Treat Prostate Cancer

(Boston Herald) Aug 11, 2016 - Researchers at Brigham and Women’s Hospital are testing a tumor-destroying technology they say could spare prostate cancer patients the sometimes devastating and life-altering consequences of standard treatments.
read article 



Immune Analysis Of On-Treatment Longitudinal Biopsies Predicts Response to Melanoma Immunotherapy

(MD Anderson) Aug 10, 2016 - Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
read press release 



New Report Shows States Are Making Progress Implementing Policies to Reduce Toll of Cancer

(ACS CAN) Aug 11, 2016 - While a majority of states are still missing important opportunities to pass and implement legislative solutions proven to prevent and fight cancer, there is progress being made to move the nation closer to ending cancer as we know it, according to a report released today by the American Cancer Society Cancer Action Network (ACS CAN).
read press release 



Two New Drugs Show Promise for Patients with Aggressive Breast Cancer

(Penn Medicine) Aug 11, 2016 - Results from I-SPY 2 study may lead to smaller, faster and more focused phase 3 trials of new therapies for patients with triple-negative and HER2-positive breast cancer.
read press release 



Heron Gains FDA Support For Nausea Drug After A Year Under Review

(Xconomy) Aug 10, 2016 - The decision that Heron Therapeutics has been waiting on for almost a year is finally in: The FDA has approved the Redwood City, CA-based company’s drug for nausea and vomiting associated with certain chemotherapy regimens.
read article 



Re-evaluate Coverage Policies For Breast Cancer

(Managed Healthcare Executive) Aug 10, 2016 - New guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider 3-D mammography exams as an option for their patients’ annual breast cancer screening, including women of average risk age 40 and over.
read article 



Conservative Group Launches Ads Against Obama Medicare ‘Experiment'

(The Hill) Aug 8, 2016 - A conservative group is launching a multimillion-dollar ad campaign against a controversial Medicare drug pricing proposal from the Obama administration.
read article 



Novartis Execs In Korea Are Indicted For Bribing Doctors

(STAT) Aug 9, 2016 - Six former and current Novartis executives at its Korean unit were indicted Monday on charges of paying more than $2 million to doctors in return for prescribing its medicines, a company spokesman confirmed. Among those indicted was the former chief executive in the country.
read article 



Biogen Unveils Name For Hemophilia Drug Spinoff: Bioverativ

(Boston Globe) Aug 9, 2016 - The hemophilia drug franchise that Biogen Inc. plans to spin off as a separate company early next year has been given a name: Bioverativ.
read article (free registration required) 



Big Driver of Medicare Spending: Doctors Doing More Tests in Their Offices

(Wall Street Journal) Aug 9, 2016 - Some of the fastest-growing Medicare costs stem from doctors using new medical devices, the latest data show.
read article (paid subscription required) 



Health IT Costs Hit $32K Per Doctor Annually

(Forbes) Aug 10, 2016 - Doctor practices spent $32,500 last year on new health IT, staff, maintenance and related costs for a 40% increase since 2009, the Medical Group Management Association said.
read article 



Essential Cancer Updates for Primary Care Physicians

(Medscape Medical News) Aug 10, 2016 - The most important meeting on cancer, the American Society of Clinical Oncology (ASCO) Annual Meeting, also includes studies that may affect primary care physicians (PCPs) in how they talk to and treat patients who have cancer, those at high risk, and cancer survivors.
read article (free registration required) 



Can Immunotherapy Cure HIV?

(Fred Hutch News Service) Aug 8, 2016 - HIV cure researchers and advocates met at Fred Hutchinson Cancer Research Center last week to explore whether immunotherapy — treatments that harness the immune system to fight cancer — could play a role in bringing about a cure or a long-term remission for HIV, the virus that causes AIDS.
read article 



ASCO Advocates for Proposed Changes to the Common Rule

(ASCO in Action) Aug 9, 2016 - ASCO met with the Department of Health and Human Services (HHS) on proposed changes to the Common Rule, which is undergoing its first revision in 30 years. ASCO reiterated its support for many proposed changes and reiterated its concerns with several areas, including the proposal to classify all biospecimens as "human subjects.”
read article 



Patient Navigation: Reducing Delays in Care

(ACCCBuzz) Aug 9, 2016 - Our last navigation blog discussed how process mapping by disease site can help in managing transitions across the continuum of care.
read article